Mizuho Medy Co.,Ltd. (TYO:4595)
Japan · Delayed Price · Currency is JPY 1,661.00
+6.00 (0.36%)
Aug 4, 2026, 12:33 PM JST
Mizuho Medy Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 10,819 | 11,260 | 11,429 | 10,989 | 17,581 | 13,137 |
Revenue Growth | -4.56% | -1.48% | 4.00% | -37.49% | 33.83% | 212.41% |
Gross Profit Gross Profit Growth | 7,425 | 7,819 | 8,084 | 8,074 | 14,099 | 9,652 |
Operating Income Operating Income Growth | 4,283 | 4,647 | 4,918 | 5,152 | 11,104 | 6,699 |
Net Income Net Income Growth | 3,249 | 3,425 | 3,773 | 3,774 | 7,838 | 4,816 |
Earnings Per Share EPS Growth | 170.56 | 179.80 | 198.07 | 396.24 | 822.93 | 505.64 |
EPS Growth | 2.10% | -9.22% | -50.01% | -51.85% | 62.75% | 1473.87% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Hospitals and Practitioner - New Coronavirus Test Drug Hospitals and Practitioner - New Coronavirus Test Drug Growth | 6,881 | 7,617 | 15,179 | - | - |
Hospitals and Practitioner - Other Testing Agents and Equipment Hospitals and Practitioner - Other Testing Agents and Equipment Growth | 3,187 | 2,070 | 1,641 | - | - |
Hospitals and Practitioner - Influenza Test Drug Hospitals and Practitioner - Influenza Test Drug Growth | 977 | 949.19 | 416.02 | - | - |
Over-the-counter and Other Fields Over-the-counter and Other Fields Growth | 382 | 352.87 | 345.8 | 414 | 411 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12,537 | 10,825 | 11,246 | 10,134 | 8,702 | 4,326 |
Total Debt Total Debt Growth | - | - | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 12,537 | 10,825 | 11,246 | 10,134 | 8,702 | 4,326 |
Net Cash Growth | 13.79% | -3.74% | 10.97% | 16.46% | 101.16% | - |
Net Cash Per Share Net Cash Per Share Growth | 658.16 | 568.28 | 590.38 | 1064.00 | 913.65 | 454.20 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,956 | 3,348 | 3,991 | 6,172 | 5,596 |
Capital Expenditures CapEx Growth | - | -255 | -299 | -263 | -179 | -154 |
Free Cash Flow Free Cash Flow Growth | - | 1,701 | 3,049 | 3,728 | 5,993 | 5,442 |
Free Cash Flow Growth | - | -44.21% | -18.21% | -37.79% | 10.13% | 2634.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.63% | 69.44% | 70.73% | 73.47% | 80.20% | 73.47% |
Operating Margin | 39.59% | 41.27% | 43.03% | 46.88% | 63.16% | 50.99% |
Pretax Margin | 41.54% | 42.05% | 45.20% | 48.16% | 62.97% | 51.94% |
Profit Margin | 30.03% | 30.42% | 33.01% | 34.34% | 44.58% | 36.66% |
FCF Margin | - | 15.11% | 26.68% | 33.92% | 34.09% | 41.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.70 | 9.48 | 7.58 | 7.92 | 4.56 | 4.66 |
P/FCF Ratio | 18.53 | 19.09 | 9.38 | 8.02 | 5.96 | 4.13 |
PS Ratio | 2.91 | 2.88 | 2.50 | 2.72 | 2.03 | 1.71 |